Loading people...
Laurence Ion is the founder and builder of viva.city, a new initiative focused on developing a specialized urban center dedicated to accelerating innovation in healthy life extension. Prior to his current venture, he co-created VitaDAO, a prominent decentralized autonomous organization that actively funds critical early-stage longevity research and advanced biotechnology development projects. Expanding his work in decentralized science, he also played a foundational role in establishing several other specialized DAOs and pop-up city communities, specifically including Zuzalu, Vitalia, and JellyfishDAO. Through his leadership across these various organizations, Ion has concentrated on leveraging decentralized governance structures and alternative funding mechanisms to advance scientific research and global health innovation outside of traditional institutional frameworks. His overarching professional focus remains on integrating biotechnology, decentralized networks, and purpose-built physical infrastructure to systematically extend human healthspans and accelerate the broader longevity sector.
Laurence Ion stands as a prominent figure in the rapidly evolving landscape of longevity investment, primarily through his significant role as an investor and active participant at VitaDAO. VitaDAO is a groundbreaking decentralized autonomous organization committed to accelerating research and development in the longevity space, leveraging a community-driven model to fund projects aimed at extending human healthspan. Ion's involvement is crucial in steering VitaDAO's strategic investment decisions and fostering innovation within this vital sector.
At VitaDAO, Laurence Ion contributes to a collective effort to identify, evaluate, and fund promising early-stage research projects that have the potential to significantly impact human aging. His expertise helps guide the DAO's treasury allocations towards initiatives in areas such as senolytics, gene therapy, regenerative medicine, and other novel approaches to combating age-related diseases. This decentralized model allows for agile and transparent funding, a paradigm shift from traditional biotech investment.
Ion's investment focus is deeply aligned with VitaDAO's mission: to unlock and democratize access to longevity science. He is particularly interested in projects that blend cutting-edge biotechnology with the principles of decentralized science (DeSci) and Web3. This includes ventures exploring new therapeutic modalities, diagnostic tools, and infrastructure that can accelerate the discovery and development of treatments for aging. His contributions help ensure that VitaDAO remains at the forefront of funding impactful, high-potential research.
While specific details of his individual career background prior to VitaDAO are not widely publicized, his active role suggests a strong foundation in finance, biotechnology, or the broader Web3 ecosystem. This blend of experience is invaluable in navigating the complex intersections of scientific innovation, financial strategy, and decentralized governance that define VitaDAO's operations. His insights are instrumental in assessing both the scientific merit and the economic viability of potential investments.
Through VitaDAO, Laurence Ion is not merely an investor but a key architect in building a future where longevity research is openly funded and its benefits are widely accessible. The DAO's portfolio of funded projects, which he helps shape, represents a diverse array of scientific breakthroughs aimed at extending healthy human life. His dedication underscores the potential of decentralized communities to drive significant progress in critical scientific fields, making him a pivotal contributor to the longevity movement.
Laurence Ion is a prominent investor and active contributor at VitaDAO, a leading decentralized autonomous organization focused on funding and accelerating longevity research. He plays a key role in identifying and supporting innovative projects aimed at extending human healthspan.
Through VitaDAO, Laurence Ion invests in cutting-edge longevity research, including projects in biotechnology, decentralized science (DeSci), aging therapeutics, and other novel approaches to combating age-related diseases. His focus is on initiatives that promise to significantly impact human healthspan.
Laurence Ion works with VitaDAO, a decentralized autonomous organization. His involvement is as an investor and active participant, contributing to the DAO's mission of funding and advancing longevity research globally.
